Barry Gause
Direttore Tecnico/Scientifico/R&S presso SAIC-Frederick, Inc.
Profilo
Barry Gause is a professional who currently works as the Chief Medical Officer at SAIC-Frederick, Inc. since 2006.
He previously worked as an Independent Director at Neogenix Oncology, Inc. in 2012 and as a Faculty Member at Howard University.
He obtained his doctorate degree from Michigan State University in 1976.
Posizioni attive di Barry Gause
| Società | Posizione | Inizio |
|---|---|---|
SAIC-Frederick, Inc.
 SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Direttore Tecnico/Scientifico/R&S | 01/11/2006 |
Precedenti posizioni note di Barry Gause
| Società | Posizione | Fine |
|---|---|---|
| Howard University | Corporate Officer/Principal | - |
Neogenix Oncology, Inc.
 Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Direttore/Membro del Consiglio | - |
Formazione di Barry Gause
| Michigan State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Neogenix Oncology, Inc.
Neogenix Oncology, Inc. Medical SpecialtiesHealth Technology Founded in December 2003, Neogenix Oncology is a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company's antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Neogenix Oncology is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials. By marrying this platform with today's breakthrough technologies, the company is developing antibody therapeutics that could change the way it detects and treats cancer. | Health Technology |
SAIC-Frederick, Inc.
SAIC-Frederick, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leidos Holdings, Inc., SAIC-Frederick, Inc. provides technical solutions and services. The company is based in San Diego, CA. David Heimbrook has been the CEO of the company since 2011. | Commercial Services |
- Borsa valori
- Insiders
- Barry Gause
